PerkinElmer

Founded in 1937, PerkinElmer is a global leader empowering scientists, researchers, and clinicians to address critical challenges across science and healthcare. The company delivers comprehensive solutions serving the diagnostics, life sciences, food, and applied markets. Its extensive portfolio includes advanced analytical instrumentation, software, and services designed for high-throughput screening, diagnostic testing, and drug discovery. PerkinElmer's commitment to innovation is demonstrated through its product lines, which encompass spectroscopy, imaging systems, and genomic solutions, supporting vital applications from newborn screening to disease detection and drug development.

PerkinElmer operates with a significant global footprint, supporting a diverse workforce and extensive operations. The company's scale is underscored by its annual revenue of $1.49B and an employee range of 5,000 - 10,000 individuals. This robust infrastructure enables PerkinElmer to provide end-to-end solutions, contributing to a healthier world through scientific advancement. For insights into the professionals driving these innovations, you can Meet PerkinElmer's team. The company's strategic focus on analytical services and laboratory solutions positions it as a key partner for organizations requiring precise measurement and testing capabilities.

In a competitive landscape featuring companies like Waters, Bruker, and Agilent Technologies, PerkinElmer leverages its broad product offerings and strategic focus to maintain market presence. Its offerings in spectroscopy, genomics, and imaging are crucial for research and clinical applications. The company's historical depth, dating back to 1937, combined with its continuous investment in technology, allows it to adapt to evolving scientific and healthcare demands, solidifying its role in advancing scientific discovery and improving global health outcomes.